RESUMO
Challenges in distinguishing between natural and engineered nanomaterials (ENMs) and the lack of historical records on ENM accidents have hampered attempts to estimate the accidental release and associated environmental impacts of ENMs. Building on knowledge from the nuclear power industry, we provide an assessment of the likelihood of accidental release rates of ENMs within the next 10 and 30 years. We evaluate risk predictive methodology and compare the results with empirical evidence, which enables us to propose modelling approaches to estimate accidental release risk probabilities. Results from two independent modelling approaches based on either assigning 0.5% of reported accidents to ENM-releasing accidents (M1) or based on an evaluation of expert opinions (M2) correlate well and predict severe accidental release of 7% (M1) in the next 10 years and of 10% and 20% for M2 and M1, respectively, in the next 30 years. We discuss the relevance of these results in a regulatory context.
Assuntos
Poluentes Ambientais , Nanoestruturas , Nanoestruturas/toxicidadeRESUMO
The convergence of nanotechnology and biotechnology has led to substantial advancements in nano-biomaterials (NBMs) used in medical devices (MD) and advanced therapy medicinal products (ATMP). However, there are concerns that applications of NBMs for medical diagnostics, therapeutics and regenerative medicine could also pose health and/or environmental risks since the current understanding of their safety is incomplete. A scientific strategy is therefore needed to assess all risks emerging along the life cycles of these products. To address this need, an overarching risk management framework (RMF) for NBMs used in MD and ATMP is presented in this paper, as a result of a collaborative effort of a team of experts within the EU Project BIORIMA and with relevant inputs from external stakeholders. The framework, in line with current regulatory requirements, is designed according to state-of-the-art approaches to risk assessment and management of both nanomaterials and biomaterials. The collection/generation of data for NBMs safety assessment is based on innovative integrated approaches to testing and assessment (IATA). The framework can support stakeholders (e.g., manufacturers, regulators, consultants) in systematically assessing not only patient safety but also occupational (including healthcare workers) and environmental risks along the life cycle of MD and ATMP. The outputs of the framework enable the user to identify suitable safe(r)-by-design alternatives and/or risk management measures and to compare the risks of NBMs to their (clinical) benefits, based on efficacy, quality and cost criteria, in order to inform robust risk management decision-making.
RESUMO
This work presents an overview about the explosion behaviour of metallic powders from micron to nanosize. Aluminium, magnesium, titanium, iron and zinc were considered and their explosion safety parameters were analysed as a function of their mean primary particle size either determined by BET measurements, particle size distribution. To depict the course of explosion behaviour for these metals, extensive literature review has been performed and additional experimental tests were also performed. Generally, decreasing the particle size in a metallic powder leads to a higher explosion severity. It appears that this statement is true till a critical diameter below which the explosion severity (pmax, dp/dtmax) decreases for all the considered powders. This critical size can be explained by theoretical considerations on the nature of thermal transfer in the flame, namely by analysing the Cassel model. Finally, semi-empirical models were also developed for aluminium to highlight the specific micrometre and nanometre behaviour and the influence of turbulence, particle burning time, diameter and concentration. The influence of these key parameters needs to be further assessed in a future work in order to better understand the mechanisms involved and to extend the scope to other powdered materials.